期刊
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY
卷 3, 期 2, 页码 149-156出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187221309788489814
关键词
IL-17; IL-17 receptors; Th-17; Th-1; Th-2; autoimmune diseases; allergic diseases; retinoids; retinoid orphan receptors; inflammation
资金
- FONACIT [G-2005000389, UCV-Sociedad PSU 09-00-6144-2005, CDCH PI 09-00-6010-2005, PG 09-00-6785-07, PG 09-006599-2006]
- CDCH-UCV [ICC09-0582 -2007, ICC09-0652-2007]
- [ICC09-0219-2008]
- [ICC09-0242-2008]
Recently, a third subset of Th17 cells has been described. This T helper subset induces the release of chemokines and growth factors and causes neutrophil accumulation in several mammalian organs. Pharmacological intervention blocking Th17 generation as well as IL-17 signaling might prove useful in a variety of diseases including asthma, chronic obstructive pulmonary disease, Crohn's disease, cystic fibrosis, multiple sclerosis, psoriatic disease and rheumatoid arthritis. Here, we describe the patents that address a potential pharmacological use of promoting or targeting IL-17.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据